BWAY · Brainsway Ltd.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-15 | Moiseyev Gilad |
Chief Technology Officer |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The sale price was NIS 42.0397 per share. This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. |
Ordinary Shares
|
5,000 |
| 2026-06-02 | Roth Yiftach |
Chief Scientist |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The sale price was NIS 43 per share. This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
1,000 |
| 2026-06-02 | Roth Yiftach |
Chief Scientist |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The sale price was NIS 42.0035 per share. This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
2,000 |
| 2026-06-01 | Roth Yiftach |
Chief Scientist |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The sale price was NIS 43.45 per share. This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
2,000 |
| 2026-06-01 | Roth Yiftach |
Chief Scientist |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The sale price was NIS 43.64 per share. This figure includes ordinary shares held jointly by Dr. Roth and his spouse and (i) 15,000 ordinary shares and (ii) unvested restricted stock units ("RSUs") to receive 5,000 ordinary shares, with 1,250 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030, each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
2,000 |
| 2026-05-26 | Mitrany Rayten Michal Ety |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The sale price was NIS 44.7516 per share. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
7,980 |
| 2026-05-25 | Moiseyev Gilad |
Chief Technology Officer |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The exercise price is NIS 11.17 per share. This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. |
Ordinary Shares
|
7,500 |
| 2026-05-25 | Mitrany Rayten Michal Ety |
Director |
Sell↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The sale price was NIS 45.5588 per share. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
10,000 |
| 2026-05-25 | Moiseyev Gilad |
Chief Technology Officer |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. These shares were retained by the Company at a price of NIS 44.04 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person. This figure includes ordinary shares and unvested restricted stock units ("RSUs"), with each RSU representing a contingent right to receive one ordinary share, as follows: (a) RSUs to receive 6,563 ordinary shares vesting in equal quarterly installments until March 5, 2028, (b) RSUs to receive 10,000 ordinary shares with 2,500 vesting on November 10, 2026 and the remainder vesting in equal quarterly installments until November 10, 2029 and (c) RSUs to receive 27,500 ordinary shares with 6,875 vesting on March 10, 2027 and the remainder vesting in equal quarterly installments until March 10, 2030. |
Ordinary Shares
|
1,902 |
| 2026-05-25 | Moiseyev Gilad |
Chief Technology Officer |
Convert↓
Filing footnotes — Stock Options (right to buy) (Direct)
The exercise price is NIS 11.17 per share. Stock options were granted on March 5, 2024, with the remaining options to purchase 13,125 ordinary shares vesting in equal quarterly installments until March 5, 2028. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Stock Options (right to buy)
|
7,500 |
| 2026-05-20 | Mitrany Rayten Michal Ety |
Director |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The exercise price is NIS 15.26 per share. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
17,500 |
| 2026-05-20 | Mitrany Rayten Michal Ety |
Director |
Convert↓
Filing footnotes — Stock Options (right to buy) (Direct)
The exercise price is NIS 15.26 per share. Stock options were granted on January 13, 2020, and were fully vested by November 28, 2023. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Stock Options (right to buy)
|
17,500 |
| 2026-05-20 | Mitrany Rayten Michal Ety |
Director |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. These shares were retained by the Company at a price of NIS 43.92 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
6,080 |
| 2026-05-19 | Mitrany Rayten Michal Ety |
Director |
Convert↑
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. The exercise price is NIS 15.26 per share. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
10,000 |
| 2026-05-19 | Mitrany Rayten Michal Ety |
Director |
Tax↓
Filing footnotes — Ordinary Shares (Direct)
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. These shares were retained by the Company at a price of NIS 44.36 per share in payment of the exercise price of the employee stock options exercised by the Reporting Person. This figure includes ordinary shares and unvested restricted stock units ("RSUs") to receive 6,250 ordinary shares that vest quarterly until March 5, 2028, with each RSU representing a contingent right to receive one ordinary share. |
Ordinary Shares
|
3,440 |
| 2026-05-19 | Mitrany Rayten Michal Ety |
Director |
Convert↓
Filing footnotes — Stock Options (right to buy) (Direct)
The exercise price is NIS 15.26 per share. Stock options were granted on January 13, 2020, and were fully vested by November 28, 2023. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
Stock Options (right to buy)
|
10,000 |